Life-threatening cardiac manifestations of primary antiphospholipid syndrome

Heart and Vessels

Volumn 25, Issue 3, 2010, Pages 267-269

  Grzybczak, Rafal ^a   Undas, Anetta ^a   Rostoff, Pawel ^a   Gackowski, Andrzej ^a   Czubek, Urszula ^a   Stopyra, Katarzyna ^a   Piwowarska, Wieslawa ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acute coronary syndrome; Primary antiphospholipid syndrome; Stent thrombosis

Indexed keywords

ABCIXIMAB; ACENOCOUMAROL; ACETYLSALICYLIC ACID; CLOPIDOGREL; METOPROLOL; OMEPRAZOLE; RAMIPRIL; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BARE METAL STENT; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; HEART ATRIUM THROMBOSIS; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; INTERNATIONAL NORMALIZED RATIO; MALE; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

ACUTE CORONARY SYNDROME; ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; CORONARY STENOSIS; HUMANS; MALE; METALS; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RECURRENCE; STENTS; THROMBOSIS; TREATMENT OUTCOME;

EID: 77956134633     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1193-7     Document Type: Article

References (17)

1. Bick RL (2001) Antiphospholipid thrombosis syndrome. Clin Appl Thromb Haemost 7:241-258
2. Schulman S, Svenungsson E, Granqvist S (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am J Med 104:332-338
3. Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J (1992) Valvular heart disease in primary antiphospholipid syndrome. Ann Intern Med 116:293-298
4. Nesher G, Ilany J, Rosenmann D, Abraham AS (1997) Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 27:27-35
5. Brandy JT, Triplett DA, Alving B, Scharer I (1995) Criteria for diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientifi c and Standardisation Committee of the ISTH. Thromb Haemost 74:1185-1190
6. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classifi cation criteria for defi nite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
7. Umesan CV, Kapoor A, Nityanand S, Tiwari S, Sinha N (1999) Recurrent acute coronary events in a patient with primary antiphospholipid syndrome: successful management with intracoronary stenting. Int J Cardiol 71:99-102
8. Vaarala O, Manttari M, Manninen V, Tenkanen L, Puurunen M, Aho K, Palosuo T (1995) Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation; 91:23-27
9. Bick RL, Arun B, Frenkel EP (1999) Antiphospholipidthrombosis syndromes. Haemostasis 29:100-110
10. Stief TW (2008) Kallikrein activates prothrombin. Clin Appl Thromb Haemost 14:97-98
11. Scully MF (2005) Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes. J Thromb Haemost 3:840-841
12. Mant MJ, Stang L, Etches WS (2000) Warfarin monitoring in patients with anticardiolipin antibodies, but without lupus anticoagulants. Thromb Res 99:477-482
13. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N (2008) Effects of drug-eluting stents on systemic infl ammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 23:75-82
14. Mori F, Tsurumi Y, Hagiwara N, Kasanuki H (2007) Impact of post-dilatation with a focal expanding balloon for optimization of intracoronary stenting. Heart Vessels; 22:152-157
15. Patterson SL, LaMonte MP, Mikdashi JA, Haines ST, Hursting MJ (2006) Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature. Pharmacotherapy 29:1518-1525
16. Otsui K, Inoue N, Kobayashi S, Shiraki R, Honjo T, Takahashi M, Hirata K, Kawashima S, Yokoyama M (2007) Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries. Heart Vessels 22:416-422
17. Pierangeli SS, Vega-Ostertag ME, Gonzales EB (2007) New targeted therapies for treatment of thrombosis in antiphospholipid syndrome. Expert Rev Mol Med 30:1-15